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The Cdk-Activating Kinase (CAK) from Budding Yeast
Philipp Kaldis,* Ann Sutton,† and Mark J. Solomon* cdk7 (Fesquet et al., 1993; Poon et al., 1993; Solomon
*Yale University et al., 1993), a regulatory subunit, cyclin H (Fisher and
School of Medicine Morgan, 1994; Ma¨kela¨ et al., 1994), and an assembly
Department of Molecular Biophysics and Biochemistry factor, MAT1 (Devault et al., 1995; Fisher et al., 1995;
New Haven, Connecticut 06520-8024 Tassan et al., 1995). A related complex with CAK activity
†State University of New York at Stony Brook in Schizosaccharomyces pombe contains Crk1/Mop1
Department of Biochemistry and Cell Biology as its catalytic subunit and Mcs2 as its regulatory sub-
Stony Brook, New York 11794 unit (Buck et al., 1995; Damagnez et al., 1995). CAK
phosphorylates not only p34cdc2 but also other Cdks,
including p33cdk2 and cdk4, which function earlier in the
cell cycle (Fesquet et al., 1993; Poon et al., 1993; Solo-Summary
mon et al., 1993; Fisher and Morgan, 1994; Matsuoka
Activation of the cyclin-dependent kinases to promote et al., 1994). Additionally, the CAK subunits are compo-
cell cycle progression requires their association with nents of TFIIH (Roy et al., 1994; Serizawa et al., 1995;
cyclins as well as phosphorylation of a threonine (resi- Shiekhattar et al., 1995; Adamczewski et al., 1996), a
due 161 in human p34cdc2). This phosphorylation is car- basal transcription factor involved in the initiation of
ried out by CAK, the Cdk-activating kinase. We have transcription, phosphorylation of the C-terminal domain
purified and cloned CAK from S. cerevisiae. Unlike (CTD) of the large subunit of RNA polymerase II, and
CAKs from other organisms, Cak1p is active as a mo- DNA repair (Drapkin and Reinberg, 1994).
nomer, has full activity when expressed in E. coli, and Regulation of the cell cycle in the budding yeast Sac-
is not a component of the basal transcription factor, charomyces cerevisiae is less complex in that there is
TFIIH. A temperature-sensitive mutation in CAK1 con- only one major Cdk, Cdc28p. Cdc28p forms complexes
fers a G2 delay accompanied by low Cdc28p protein with various cyclins (Clbs and Clns) during different
kinase activity and shows genetic interactions with phases of the cell cycle. The major mitotic cyclins are
altered expression of the gene for the major mitotic Clb1p and Clb2p (Surana et al., 1991). Like its higher
cyclin, CLB2. Our data raise the intriguing possibility eukaryotic homologs, Cdc28p requires an activating
that p40MO15–cyclin H–MAT1, identified as the predomi- phosphorylation, on Thr-169 (Cismowski et al., 1995;
nant CAK in vertebrate cell extracts, may not function Deshaies and Kirschner, 1995).
as a physiological CAK. A candidate for the catalytic subunit of CAK in yeast
had been the product of the KIN28 gene (Simon et al.,
Introduction 1986). At 47% identity, Kin28p is the yeast protein most
similar to p40MO15 and shows homology to Cdks in gen-
The transitions between the phases of the cell cycle are eral. The binding partner of Kin28p, Ccl1p (Valay et al.,
controlled by a family of protein kinases termed cyclin- 1993), is related to cyclin H. Moreover, yeast Kin28p
dependent kinases (Cdks; for reviews see Norbury and and Ccl1p are subunits of TFIIH (Feaver et al., 1994;
Nurse, 1992; Solomon, 1993; King et al., 1994; Morgan, Svejstrup et al., 1996), like their human counterparts
1995; Pines, 1995). The founding member of this group, p40MO15 and cyclin H. Although Kin28p is the CTD kinase
p34cdc2, was first identified by genetic screens in fission in yeast TFIIH, it does not show CAK activity (Feaver
yeast. At least three posttranslational mechanisms con- et al., 1994; Cismowski et al., 1995). Furthermore, we
trol Cdk activity: binding to positive regulatory subunits
showed previously that, although CAK activity could be
(cyclins), association with inhibitory proteins (CKIs), and
readily detected in yeast extracts, quantitative immuno-
phosphorylations. The mitotic cyclins, which bind to
depletion of Kin28p precipitated noneof theCAK activityp34cdc2, accumulate periodically during the cell cycle and
(Cismowski et al., 1995). Yeast thus has two distinctreach maximal levels at the start of mitosis just prior
enzymes for the CAK and TFIIH functions, which areto their sudden degradation, which initiates exit from
apparently both performed by p40MO15 in higher eu-mitosis.p34cdc2 activity is additionally regulated by phos-
karyotes.phorylations on threesites. Inhibitory phosphorylation of
We therefore sought to identify CAK in budding yeast.Thr-14 and Tyr-15, both located within the ATP-binding
We have purified and cloned the gene for yeast CAKregion of p34cdc2, keep the newly formed cyclin–p34cdc2
and established its role in Cdc28p activation both incomplexes inactive. Removal of these phosphorylations
vivo and in vitro. Cak1p is less than 25% identical toby the cdc25 protein phosphatase leads to activation
its closest Cdk homologs, Kin28p and p40MO15. Unlikeof p34cdc2 and entry into mitosis. In contrast, an activating
vertebrate CAK, yeast Cak1p was active as a monomerphosphorylation of Thr-161 persists into mitosis and is
and was apparently fully active when expressed in Esch-absolutely required for p34cdc2 activity.
erichia coli. Moreover, Cak1p is not a subunit of yeastAn activity capable of phosphorylating p34cdc2–cyclin
TFIIH. Genetic evidence indicates that Cak1p is theB complexes on Thr-161 has been termed CAK, for the
physiological CAK in budding yeast. These data suggestCdk-activating kinase. Purification of CAK from mam-
that there may be an additional CAK, similar to Cak1p,mals, starfish, and Xenopus identified it as a heterotrim-
eric complex composed of a catalytic subunit, p40MO15/ in vertebrate cells.
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Table 1. Purification of CAK from S. cerevisiae
Specific Activity Total Activity Fold
Volume (ml) Total Protein (mg) (unitsa/mg) (units) Purification Yield (%)
Yeast extract 1960 15300 1.3 19600 1 100
Acetone precipitation 105 6800 0.8 5460 0.6 27.8
DEAE 144 450 9.5 4250 7.4 21.6
Ammonium sulfate 2.5 66 38.0 2510 29.7 12.8
Phosphocellulose 4.2 57 31.1 1780 24.3 9.0
Hydroxyapatite 44 11.6 238 2760 186 14.0
Superdex 200 7.0 2.7 285d 756d 222d 3.9d
Mono Q 5.0 0.20b 7370 1470 5760 7.5
Superdex 75 2.5 0.03b 16800d 504d 13100d 2.6d
Mono P 3.0 0.002c 421000 841 329000 4.3
a One unit of CAK activity is defined as the amount in 100 ml of crude yeast extract. See Experimental Procedures for details of the assay.
b Estimated by optical density at 280 nm (from the chromatogram).
c Determined by amino acid analysis of the excised band.
d Assayed after concentration, resulting in suppressed activity (approximately 2-fold).
Results
Purification of CAK
CAK activity was assayed as previously described (Cis-
mowski et al., 1995). In brief, samples were incubated
with E. coli–expressed p33cdk2–glutathione S-transferase
(GST)–cyclin B complexes, which were then assayed for
their histone H1 kinase activity. CAK from S. cerevisiae
was purified using a combination of differential precipi-
tation and column chromatography (Table 1). The CAK
activity and protein profiles from fractions of the last
two columns are shown in Figure 1. CAK activity eluted
from the Superdex 75 column with a peak at a size of
z30 kDa (Figure 1A). After chromatofocusing on a Mono
P column, a major band at 43 kDa and a minor band at
45 kDa coeluted with CAK activity (Figure 1B). Although
the CAK assay is somewhat imprecise, we estimate that
CAK was purified over 300,000-fold from the crude ex-
tract with a yield of about 4% (Table 1).
The43 kDa protein was excised from a polyacrylamide
gel, and tryptic fragments were subjected to Edman
degradation. Sequencing of three peptides, encom-
passing 35 amino acids, revealed perfect matches to
open reading frame YFL029C of chromosome VI re-
leased as part of the S. cerevisiae genome project (Mur-
akami et al., 1995). These peptides span residues 156–
174, 315–323, and 361–368 of the predicted protein. This
gene, which we have named CAK1, is essential (data
not shown). The relationship of the 45 kDa protein to
CAK remains unclear. As shown below, however, Cak1p
produced in E. coli appears to be fully active in vitro.
Although Cak1p, like p40MO15 and Kin28p, is most simi-
lar to members of the Cdk family of protein kinases, it
displays only 20%–25% sequence identity to its closest
homologs and differs even in highly conserved regions
of protein kinases (Figure 2A). It lacks all the glycines Figure 1. Purification of CAK
of the subdomain I GxGxxG motif (Hanks and Quinn, Fractions from Superdex 75 (A) and Mono P (B) columns were ana-
lyzed by silver staining following SDS–PAGE (upper panels) and1991) common to protein kinases, having instead
assayed for their CAK activity (lower panels). CAK activity was mea-DxTxxQ. Two other nearly invariant residues are also
sured by activation of the histone H1 kinase activity of p33cdk2–cyclinreplaced in Cak1p: leucine in place of glycine at position
B. Molecular mass standards are indicated in kilodaltons at the231 in subdomain IX and aspartic acid in place of argi-
right. Gel filtration standards in (A) included chicken ovalbumin (frac-
nine at position 333 in subdomain XI. The alignment tions 20 and 21) and horsemyoglobin (fraction 25). PeakCAK activity
in Figure 2A predicts that Thr-192 might be a site of was found in fractions 52–57 of the Mono P column containing a
predominant 43 kDa protein.activating phosphorylation.
CAK in Budding Yeast
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Figure 2. Cak1p Isan Unusual ProteinKinase
(A) Protein sequence comparison of Cak1p
with p40MO15 (human [Hs] and Xenopus [Xl]),
Crk1 (S. pombe [Sp]), and Kin28p (S. cerevis-
iae [Sc]). Identical amino acids are boxed in
black; stippling indicates that two amino
acids are each present in two of the se-
quences. The subdomain I GxGxxG motif is
underlined, and a potential activation site
(Thr-192) in Cak1p is marked with a star. The
alignment was madeusing the default param-
eters of the Pileup program (GCG suite of
program) and was adjusted by eye.
(B) Phylogenetic comparison of Cak1p with
p34cdc2 homologs, CAKs, and Kin28p. Protein
sequences were aligned by the unweighted
pair group method with arithmetic mean
(UPGMA) using the GeneWorks program.
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Figure 3. Purified CAK Activates and Phosphorylates Cdc28p and p33cdk2
CAK purified through the Mono P column was used to activate (A) or phosphorylate (B) Cdc28p (left panels) and p33cdk2 (right panels). Activation
(measured as histone H1 kinase activity of the Cdk) and direct phosphorylation were assayed in the presence or absence of CAK, Cdc28p,
Clb2p, p33cdk2, cyclin B, or cyclin A, as indicated. T160A, T160E, and N132A denote the respective mutations in p33cdk2.
A phylogenetic comparison of Cak1p with p34cdc2 ho- did not lead to activation of the Cdk (Figure 3A, lanes 4
and 9). We do not know whether this cyclin-independentmologs, reported CAK catalytic subunits, and Kin28p
emphasizes the distinctiveness of Cak1p (Figure 2B). phosphorylation occurs in vivo; similarly, the physiologi-
cal relevance of cyclin-independent phosphorylation ofThe p34cdc2 homologs from humans, S. cerevisiae, and
S. pombe form a cluster, as do the p40MO15 homologs p33cdk2 by p40MO15 is unclear (Fesquet et al., 1993; Poon
et al., 1993; Solomon et al., 1993). Cak1p also phosphor-from humans, Xenopus, and S. pombe. Kin28p, though
not a CAK, clusters with the reported CAKs, presumably ylated a catalytically inactive mutant of p33cdk2 (N132A),
but it did not phosphorylate T160A and T160E mutantsreflecting their common function as TFIIH subunits with
CTD kinase activity. Cak1p is part of neither cluster. of the activating site (Figure 3B, lanes 10–12).
Interestingly, cyclin was phosphorylated even in theRather, Cak1p diverged from the other protein kinases
well before the p34cdc2 and CAK/Kin28p branches sepa- absence of an activating phosphorylation of p33cdk2 (Fig-
ure 3B, lanes 6, 11, and 12). This result suggests thatrated from each other.
these p33cdk2 proteins may not be completely inactive,
at least toward a directly bound substrate. AlthoughPurified CAK Phosphorylates Both Cdc28p
and p33cdk2 our experiments used a B-type cyclin, p33cdk2 bound to
cyclin A is known to have about 1% activity in the ab-Purified CAK was assayed for its ability to activate
Cdc28p or p33cdk2. Although CAK was purified on the sence of Thr-160 phosphorylation (Connell-Crowley et
al., 1993).basis of its ability to activate human p33cdk2, it could also
activate Cdc28p in the presence of the Clb2p cyclin We have been unable to detect CTD kinase activity
in any of our CAK preparations (purified, recombinant(Figure 3A, lane 2). Activation did not take place if
Cdc28p, Clb2p, or CAK was omitted (Figure 3A, lanes [see below] or immunoprecipitated [data not shown]).
Kin28p readily phosphorylated the CTD peptide under1,3, and 4).Cak1p itself had no histone H1 kinase activity
(Figure 3A, lanes 3 and 4; data not shown). Similarly, the same conditions. These results are consistent with
the observation that Cak1p never eluted in a large com-p33cdk2 was activated by CAK in the presence of either
cyclin A or B (Figure 3A, lanes 5 and 6). Mutant p33cdk2 plex in gel filtration experiments and indicate that Cak1p
is most likely not a subunit of TFIIH.proteins containing a nonphosphorylatable residue (ala-
nine or glutamic acid) in place of Thr-160 were not acti-
vated by CAK, indicating that activation proceeds via Recombinant GST–Cak1p Is Active as a Monomer
We verified that Cak1p had CAK activity using recombi-phosphorylation of this residue (Figure 3A, lanes 7
and 8). nant Cak1p–HA expressed in E. coli as a fusion to GST.
GST–Cak1p activated Cdc28p–Clb2p complexes (Fig-Purified CAK directly phosphorylated Cdc28p and
p33cdk2 in the presence of radiolabeled ATP (Figure 3B, ure 4A, lane 2) as well as p33cdk2–cyclin B complexes
(Figure 4B, lane 2). In the latter case, all the proteinslanes 2 and 7). We were surprised to find that phosphory-
lation did not require binding of the Cdk to a cyclin used, GST–Cak1p, p33cdk2, and cyclin, were purified from
bacteria. Activation of the Cdks was only observed when(Figure 3B, lanes 4 and 9), although this phosphorylation
CAK in Budding Yeast
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Figure 4. Cak1p Has CAK Activity as a Mono-
mer and Is the Predominant CAK In Vitro
(A and B) Activation reactions were carried
out in the presence orabsence of GST–Cak1p
purified from E. coli and Cdc28p–Clb2p (A)
or p33cdk2–cyclin B (B), as indicated. N132A,
T160A, and T160E denote the corresponding
mutations in p33cdk2.
(C) Immunoprecipitation of Cak1p–HA from a
crude yeast extract. Extracts from a wild-type
(wt) strain (SY89; lanes 1–3) and from a
Cak1p–HA strain (SY191; lanes 4–9) were im-
munoprecipitated using the 12CA5 mono-
clonal antibody. Total (T; lanes 1, 4, and 7),
supernatant (S; lanes 2, 5, and 8), and pellet
(P; lanes 3, 6, and 9) fractions were analyzed
for CAK activity (lanes 1–6) and by immu-
noblotting with the 12CA5 antibody (lanes
7–9).
(D) Overexpression of CAK1 in yeast in-
creases CAK activity. A wild-type yeast strain
(wt; SY240) and strains containing CAK1 on
a YCp50 plasmid (low copy, YCp; SY80),
on YEp24 (multicopy, YEp; SY89), and on
YCpGAL (galactose promoter, GAL; SY50)
were grown in CM lacking uracil and con-
taining galactose. Cultures were harvested in
log phase, and extracts were assayed for
CAK activity. The CAK activities are relative
to that of the YCp50-CAK1 strain.
GST–Cak1p, Cdk, and cyclin were present together, and lanes 7–9). We conclude that Cak1p is responsible for
the bulk, if not all, of the CAK activity in yeast extracts.GST–Cak1p did not activate the N132A, T160A, and
T160E mutants of p33cdk2 (Figure 4B, lanes 5–7). Further-
more, incubation of GST–Cak1p in a yeast extract failed
Overexpression of Cak1p Increases CAK Activityto enhance its activity (data not shown). These results
We determined whether Cak1p levels were limiting forindicate that Cak1p has CAK activity in vitro and that
CAK activity by expressing CAK1 from its own promoterit needs neither an activating phosphorylation (unless
on a low or a high copy plasmid or from a strong galac-provided via autophosphorylation or phosphorylation by
tose-inducible promoter. Extracts were prepared fromCdc28p or p33cdk2) nor association with a regulatory pro-
equal amounts of cells from log-phase cultures growntein for this activity. In contrast, all other identified CAKs
in galactose-containing medium. The CAK activity ofexist in either a dimeric form (which requires an activat-
these extracts correlated directly with expression levelsing phosphorylation) or a trimeric form (Fisher et al.,
of CAK1 and was 55-fold higher from the strain express-1995; Tassan et al., 1995).
ing CAK1 from the galactose promoter than from the
strain expressing CAK1 from its own promoter on a
Cak1p Is the Predominant CAK in Yeast Extracts low copy plasmid (Figure 4D). Although the reason is
Immunoprecipitation of Cak1p from yeast extracts was unclear, CAK activity was consistently higher when
used to determine whether it accounts for the major CAK1 was expressed from its endogenous chromo-
CAK activity. A yeast strain was constructed in which somal location than when it was expressed from its
CAK1 was deleted and replaced by a gene encoding own promoter on a low copy plasmid. Nevertheless,
Cak1p tagged at its C-terminus with a double repeat of expression from the galactose promoter increased CAK
the influenza hemagglutinin epitope tag (HA; see Experi- activity 15-fold from even this wild-type level. We ob-
mental Procedures). Extracts from CAK1 and CAK1–HA served no obvious phenotypic effect of CAK1 overex-
strains were prepared and immunodepleted using the pression.
12CA5 monoclonal antibody against the HA epitope.
CAK assays were performed on the starting material,
on the supernatant, and on the pellet fraction (Figure Mutation in CAK1 Causes a Cell Cycle Delay in G2
Mutations in CAK1 were independently identified in a4C). CAK activity was not depleted in the control (CAK1)
extract (Figure 4C, lanes 1 and 2), and virtually no CAK synthetic lethal screen with SIT4 (A. S., unpublished
data). SIT4 encodes the catalytic subunit of a proteinactivity was detected in the pellet (Figure 4C, lane 3). In
contrast, immunoprecipitation of Cak1p–HA removed phosphatase required late in G1 for normal accumula-
tion of CLN1 and CLN2 transcripts (Fernandez-Sarabianearly all of the CAK activity from the supernatant frac-
tion (Figure 4C, lane 5) and strong activity was recovered et al., 1992).The cak1-1 mutation causes a growth defect
and phenotypes characteristic of a G2 delay (A. S., un-in the pellet fraction (Figure 4C, lane 6). Immunoblotting
confirmed the precipitation of Cak1p–HA (Figure 4C, published data). A temperature-sensitive allele of CAK1
Cell
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Figure 5. The cak1-22 Mutant Arrests with
Elongated Buds
(A) Growth of isogenic CAK1 (SY162)
and temperature-sensitive cak1-22 (SY143)
strains on YPD at 248C and 378C.
(B) Wild-type (CY182) and cak1-22 (SY143)
strains were grown for 7 hr at 378C in YPD.
The morphology of the cells is shown using
Nomarski optics, DAPI staining of DNA, and
indirect immunofluorescence using the YOL/
34 antibody to detect tubulin. cak1-22 cells
arrested with elongated buds, increased cell
size, and short spindles. The bar represents
8 mm.
(C) DNA contents of isogenic CAK1 (CY182)
and cak1-1 (SY6) asynchronous cells were
determined by flow cytometry.
was subsequently created using alanine-scanning mu- DNA content compared with the isogenic CAK1 stain
(Figure 5C). Such an enrichment could result from atagenesis (Gibbs and Zoller, 1991). In the cak1-22 mu-
tant, residues Glu-313, Lys-314, and Asp-315 were re- shortened G1 phase or an elongated G2 or M phase.
Flow cytometry analysis also revealed that the cak1-1placed by two alanines, creating a strain that grew at
nearly wild-type rates at 248C, but that did not grow at cells were considerably larger than wild-type cells (data
not shown), which suggests that the mutants had a378C (Figure 5A).
cak1-22 cultures ceased cell division after about 5 hr lengthened G2 or M phase, since a shortened G1 phase
results in smaller cells.at 378C and became enriched in large-budded cells.
Approximately 65% of the cak1-22 cells were budded
after 7 hr at the restrictive temperature, compared with Inactivation of CAK Activity
We investigated the effect on CAK activity of a shift to52% budded when grown at 248C and 54% budded for
the isogenic wild-type strain grown for 7 hr at 378C. The restrictive temperature in the cak1-22 mutant. In the
first approach, extracts prepared from cells grown atmorphology of the cells maintained at the restrictive
temperature for 7 hr is shown in Figure 5B. The cak1- permissive temperature were incubated at the restrictive
temperature in vitro and then assayed for CAK activity22 cells became elongated after the temperature shift.
Of the budded cak1-22 cells at 378C, 92% were elon- (Figure 6A). An extract from wild-type cells retained
>70% of its CAK activity even after incubation at 378Cgated, had elongated buds, or both. Most of the budded
cells had a short spindle spanning an undivided nucleus for 90 min. In contrast, an extract prepared from the
cak1-22 mutant cells lost over 75% of its CAK activityat the mother/bud neck, characteristic of an arrest in
late G2. This phenotype is similar to that caused by in just 30 min and over 99% of its CAK activity by 90
min at 378C. This experiment further supports the Cak1pdeficiency in mitotic cyclins (Fitch et al., 1992; Richard-
son et al., 1992) or by overexpression of SWE1, which immunoprecipitation data and indicates that Cak1p is
responsible for essentially all of the detectable CAKinactivates Cdc28p via Tyr-19 phosphorylation (Booher
et al., 1993). In addition, cak1-1 cells exhibited a G2 activity in yeast extracts.
CAK activity was also measured from cells that haddelay as shown by the enrichment in cells with a 2N
CAK in Budding Yeast
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whereas the activity of the mutant cells decreased to
23% of the starting activity (Figure 6B). Purified CAK
that was added to the extract from heat-treated cak1-
22 cells retained its activity, indicating that CAK inactiva-
tion was not due to the action of a diffusible inhibitor
(data not shown).
Finally, we determined theeffect of inactivating Cak1p
on Cdc28p activity and phosphorylation in vivo. An HA-
tagged CDC28 gene was introduced on a plasmid into
the cak1-22 strain and into a wild-type strain. Extracts
were prepared every hour from cells shifted to 378C.
Cdc28p–HA was immunoprecipitated and assayed for
histone H1 kinase activity. In wild-type cells, Cdc28p
retained over 80% of its starting activity after 5 hr at
378C. However, Cdc28p activity from the cak1-22 mutant
cells dropped quickly, declining to less than 10% of the
starting value by 5 hr at 378C (Figure 6C). We verified that
this decreased activity was accompanied by decreased
phosphorylation of Thr-169 in vivo by analyzing Cdc28p
immunoprecipitated from cells labeled with 32P during
incubation at 378C (Figure 6D, compare lanes 1 and 2).
These results are consistent with a physiological role
for Cak1p in Cdc28p phosphorylation and activation.
Genetic Interactions between CAK1 and CLB2
The role of CAK1 during the G2 to mitosis transition
was investigated by testing for genetic interactions with
alterations in mitotic cyclin expression. The decline in
Cdc28p activity, the G2 delay, and the accumulation of
G2/M cells in CAK1 mutants suggested that a major role
for Cak1p was executed at this point in the cell cycle.
CLB2 encodes the major mitotic cyclin. Strains deleted
for CLB2 survive, presumably owing to expression of
CLB1, which also functions at this stage of the cell cycle;
strains deleted for both CLB1 and CLB2 are inviable
(Surana et al., 1991; Fitch et al., 1992; Richardson et al.,
1992). Cells deleted for CLB2 or containing the cak1-22Figure 6. G2-Arrested cak1-22 Cells Display Low CAK and Cdc28p
mutation grew nearly as well as wild-type cells at 308CActivities
(Figure 7A). In contrast, the double mutant containing(A) Extracts were prepared from isogenic wild-type (SY162) and
cak1-22 (SY143) strains grown at 168C in CM medium lacking leu- cak1-22 and deleted for CLB2 grew poorly even at 248C
cine. The extracts were incubated at 378C in vitro for the indicated (data not shown) and was inviable at 308C (Figure 7A).
times and assayed for CAK activity. Our interpretation is that the CAK activity of the cak1-
(B) The same strains were grown at 238C and shifted to 378C for
22 cells was already reduced at 308C, but was sufficientthe indicated times. Extracts were prepared and assayed for CAK
for Cdc28p activation and growth of an otherwise normalactivity.
cell. However, deletion of CLB2 further compromised(C) Same as (B) except that the strains (PKY104 [CAK1] and PKY101
[cak1-22]) also contained CDC28–HA on a low copy plasmid. Cdc28p activity to the point where the cells could not
Cdc28p–HA was immunoprecipitated using the 12CA5 antibody and progress through the cell cycle, resulting in the lower
assayed for histone H1 kinase activity. Equal amounts of protein restrictive temperature. cak1-22, Dclb1 mutant cells also
were used for each experiment. grew more slowly at a semipermissive temperature than
(D) Same as (C) except that the cells were incubated for 3 hr with
did strains with a single mutation in either gene (A. S.,32P beginning 2 hr after the shift to 378C followed by immunoprecipi-
unpublished data).tation of Cdc28p from cell lysates. The upper band represents plas-
mid-derived Cdc28p–HA and the lower band represents endoge- We performed the converse experiment, testing the
nous Cdc28p. Lane 1, strain PKY104 (CAK1); lane 2, strain PKY101 effect of CLB2 overexpression on the growth of the
(cak1-22); lane 3, strain PKY105 (CAK1) in which the Cdc28p–HA cak1-22 mutant strain. A low copy number plasmid ex-
contained a T169A mutation of the CAK phosphorylation site. Note pressing CLB2 under the control of the ADH promoterthat essentially all Cdc28p phosphorylation occurs on Thr-169 in
was introduced into cak1-22 cells. The ADH promotervivo (Cismowski et al., 1995).
results in moderate levels of constitutive CLB2 tran-
scription (data not shown). This overexpression of CLB2
partially suppressed the growth defects of the cak1-22been shifted to the restrictive temperature prior to ex-
tract preparation (Figure 6B). Extracts were prepared strain at 378C (Figure 7B), although it could not suppress
the lethality caused by deletion of CAK1 (data notfrom both wild-type and cak1-22 mutant cells every hour
following the temperature shift. The CAK activity from shown). Thus, extra mitotic cyclin protein can partially
overcome a reduction in CAK activity, presumably bywild-type cells actually increased during growth at 378C,
Cell
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in which the cell cycle defect of cak1-22 cells was exac-
erbated when mitotic cyclin levels were reduced and
was partially suppressed when the cyclin levels were
elevated.
CAK1 Encodes an Unusual Protein Kinase
Although Cak1p is clearly a member of the large Cdk
family of protein kinases, its sequence has a number of
unusual features. Most notable is the complete absence
of the three conserved glycines within the subdomain I
GxGxxG motif of protein kinases (Hanks and Quinn,
1991), a sequence that forms a loop important for bind-
ing ATP. The first two of these glycines are found in
almost all protein kinases. While some protein kinases
lack one glycine, only a few, such as mik1 and Vps15p,
lack all three (Herman et al., 1991; Lundgren et al., 1991).
It appears that this motif is replaced by DxTxxQ inCak1p
(Figure 2A). Whether and how this sequence can adopt
a typical subdomain I fold will have to await structural
analysis of Cak1p. Two other replacements of nearly
invariant amino acids occur at Leu-231 (instead of a
glycine) in subdomain IX and at Asp-333 (instead of an
arginine) within subdomain XI. Thus, nonconservative
replacements occur at 4 of the 15 nearly invariant amino
acid positions in protein kinases. Nevertheless, the se-
quence shown for Cak1p in Figure 2A represents a fully
functional protein kinase as indicated by the activity of
the GST–Cak1p fusion protein.
The Functions and Regulation of Cak1p
Although we have focused on the role of Cak1p during
the G2 to mitosis transition, it may well function at otherFigure 7. Genetic Interactions between CAK1 and CLB2
cell cycle transitions as well. cdc28 mutant cells can(A) Wild-type (W303-1B), Dclb2 (SY226), cak1-22 (SY209), and cak1-
arrest in either G1 or G2 (Piggott et al., 1982; Reed and22 Dclb2 (SY227) strains were grown at 308C for 2 days.
Wittenberg, 1990). At restrictive temperature, approxi-(B) A wild-type strain (SY80), a cak1-22 Dclb2 strain carrying
CLB2–HA on a YCp50 plasmid (SY231), and a cak1-22 Dclb2 strain mately 35% of cak1-22 cells arrested in G1 as large,
carrying pADH–CLB2–HA on a YCp50 plasmid (SY232) were grown unbudded cells. Moreover, cak1-22 cells are hypersen-
at 378C for 3.5 days. sitive to mating factor (A. S., unpublished data), consis-
tent with a block at START. The G2 defects of the CAK1
mutants suggest that the G2/M activity of Cdc28p maydriving more Cdc28p molecules into complexes with
cyclin that are potentially capable of activation. be most sensitive to reductions in CAK activity, perhaps
because that is when Cdc28p activity is highest and the
most Cdc28p molecules would need to be phosphory-Discussion
lated by Cak1p. It was interesting that cell cycle arrest
did not occur until 5–7 hr after shifting the cak1-22 strainWe have purified and cloned the Cdk-activating kinase
(CAK) from budding yeast. The identification of CAKs to the restrictive temperature despite the more rapid
inactivation of Cak1p itself. One possibility is thatfrom other species has relied upon biochemical fraction-
ation of in vitro activities. Although we took a similar Cdc28p may remain phosphorylated on Thr-169 even
after cyclin degradation (Hadwiger and Reed, 1988); ar-approach, our biochemical analysis was complemented
by in vivo experiments, which point to a physiological rest would not occur until this site became dephosphor-
ylated or the phosphorylated Cdc28p became dilutedrole for Cak1p as a bona fide CAK. In vitro experiments
demonstrated that Cak1p is the major CAK in yeast by cell growth.
Cak1p may phosphorylate other protein kinases thatextracts and that recombinant Cak1p can directly phos-
phorylate and activate either Cdc28p or p33cdk2. cak1- require activating phosphorylations. Some of the possi-
ble targets for activation by Cak1p includeCdc7p, which22 cells grown at restrictive temperature had strongly
reduced CAK and Cdc28p activities as well as reduced is involved in the initiation of DNA synthesis (Sclafani
and Jackson, 1994), Pho85p, which is involved in bothCdc28p phosphorylation, indicating that Cak1p is the
major CAK in vivo. cak1-22 mutant cells were blocked transcription and G1 progression (Espinoza et al., 1994;
Measday et al., 1994; Schneider et al., 1994; O’Neill etin progression from G2 to mitosis, consistent with an
essential role in mitotic Cdc28p activation. This sugges- al., 1996), and protein kinases involved in transcription
such as Srb10p (Liao et al., 1995) and Kin28p (Simontion was strengthened by genetic interactions of cak1-
22 with CLB2, which encodes the major mitotic cyclin, et al., 1986; Feaver et al., 1994). The identification of
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additional conditional alleles of CAK1 may help to sort The high similarity and phylogenetic clustering of the
out the possibly diverse functions of Cak1p. p40MO15 proteins, Crk1/Mop1, and Kin28p suggests that
each performs the same basic role in its respective or-
ganism. Since Kin28p functions only as a componentCAKs in Different Species
of TFIIH, and not as a CAK, we suggest that all of theseSubunits of CAK have been reported from a number of
proteins may function primarily during transcription. Al-species, including humans, mice, Xenopus, starfish, and
though the vast majority of detectable CAK activity inS. pombe. These enzymes contain a catalytic subunit
vitro is associated with p40MO15, there is no physiological(Crk1/Mop1 in S. pombe, p40MO15/cdk7 in the other spe-
evidence that either p40MO15 or Crk1/Mop1 acts as acies), an essential cyclin-like regulatory subunit (Mcs2
CAK in vivo. In contrast, while the biochemical evidenceor cyclin H), and, in some forms, an assembly factor
indicates that Cak1p is associated with most or even(MAT1) (Fesquet et al., 1993; Poon et al., 1993; Solomon
all of the detectable CAK activity in yeast extracts, addi-et al., 1993; Buck et al., 1995; Damagnez et al., 1995;
tional in vivo evidence argues that Cak1p is the physio-Devault et al., 1995; Fisher et al., 1995; Tassan et al.,
logical CAK. We have not yet detected a Cak1p-like CAK1995). CAK can exist in these dimeric and trimeric forms
in other species by database searching; further workor as part of TFIIH (Roy et al., 1994; Serizawa et al.,
will be necessary to determine whether there is a func-1995; Shiekhattar et al., 1995; Adamczewski et al., 1996).
tionally equivalent protein in other eukaryotes.These catalytic subunits display at least 45% identity in
pairwise comparisons. Kin28p performs a similar tran-
scriptional function as a subunit of yeast TFIIH (Feaver
Experimental Procedureset al., 1994) and binds to a cyclin-like protein, Ccl1p
(Valay et al., 1993). Consistent with this functional simi- Yeast Strains and Media
larity, Kin28p also displays 45%–50% identity to each The yeast strains used in this study are based on W303-1A (unless
of the catalytic subunits mentioned above. However, as otherwise specified): MATa ade2-1 his3-11,15 leu2-3,112 can1-100
ura3-1 trp1-1 ssd1-d (R. Rothstein). The genotypes of the specificwe showed previously, Kin28p does not function as a
strains used are as follows:CAK (Cismowski et al., 1995).
CY182, MATa his3D200 leu2-3 ura3-52 lys2 SSD1-v (K. Arndt);Cak1p from budding yeast differs significantly from
PKY101, cak1::HIS3 (LEU2/cen-cak1-22; TRP1/cen-CDC28–HA);
these other CAKs and from Kin28p, showing only 20%–
PKY104, cak1::HIS3 (LEU2/cen-CAK1; TRP1/cen-CDC28–HA);
25% amino acid identity to each of the other catalytic PKY105, cak1::HIS3 (LEU2/cen-CAK1; TRP1/cen-CDC28 T169A–
subunits. Moreover, Cak1p is active as a monomer in HA); SY6, cak1-1 in a CY182 background; SY50, cak1::HIS3
vitro. This conclusion is supported by the purification, (pGAL:CAK1); SY80, cak1::HIS3 (YCp50-CAK1); SY89, cak1::HIS3
(YEp24-CAK1); SY143, cak1::HIS3 (LEU2/cen-cak1-22); SY162,by the estimated size of CAK activity on gel filtration
cak1::HIS3 (LEU2/cen-CAK1); SY191, cak1::HIS3 (YEp24-CAK1–columns (z30 kDa), by the observation that CAK1 over-
HA2); SY209, cak1::HIS3 (TRP1/cen-cak1-22); SY226, cak1::HIS3expression in vivo leads to elevated CAK activity, and
clb2::LEU2 (TRP1/cen-CAK1); SY227,cak1::HIS3 clb2::LEU2 (TRP1/by the finding that a GST–Cak1p fusion protein made
cen-cak1-22); SY231, MATa cak1::HIS3 clb2::LEU2 (TRP1/cen-
in E. coli has full CAK activity. The activity of GST–Cak1p cak1-22; YCp50-CLB2–HA); SY232, MATa cak1::HIS3 clb2::LEU2
also indicates that Cak1p is active in vitro in the absence (TRP1/cen-cak1-22; YCp50-ADH–CLB2–HA); SY240, W303-1A
of any trans-acting factors (either kinases or binding (YEp24).
Yeast extract–peptone–dextrose (YPD) medium contained 1%partners), another contrast with the previously identified
yeast extract, 2% Bacto-peptone, and2% glucose; YPGal containedCAKs. Cak1p appears to have no CTD kinase activity,
2% galactose instead of glucose; complete minimal (CM) mediumhas not been reported to be a component of yeast TFIIH,
included all essential amino acids, uracil, adenine, and 2% glucoseand is not part of any large assembly. Finally, overex-
or galactose (Ausubel et al., 1995).
pression of Xenopus p40MO15, or of both Kin28p and A fragment extending 846 bp upstream from the CAK1 ATG and
Ccl1p, fails to suppress the temperature sensitivity of a 261 bp downstream of the CAK1 termination codon was used for
cak1-22 strain (data not shown), indicating that neither most of the CAK1 expression constructs and was cloned following
blunting into the BamHI sites of the indicated vectors. The equivalentp40MO15 nor Kin28p can perform the essential functions
fragment was used for CAK1, cak1-22, and CAK1–HA2. The LEU2/of Cak1p in vivo.
cen vector contained a LEU2 fragment in place of the URA3 gene
in YCp50. The TRP1/cen vector contained an EcoRI–PstI fragment
Is There Another CAK in Higher Eukaryotes? of TRP1 in placeof a SalI–SmaI fragment containing URA3 in YCp50.
The pGAL–CAK1 vector contained a fragment of CAK1 extendingIt is surprising that a single protein kinase catalytic sub-
from 13 bp upstream of the ATG to 261 bp downstream of theunit (p40MO15/cdk7 or Crk1/Mop1) should be used for
termination codon inserted next to a GAL1 promoter in the YCp50both TFIIH and CAK functions in mammals, Xenopus,
vector. For disruption of CAK1, a 685 bp NsiI–XbaI fragment of CAK1
starfish, and fission yeast, whereas distinct catalytic was replaced with a 1.8 kb BamHI fragment of HIS3 in the opposite
subunits (Kin28p and Cak1p, respectively) perform transcriptional orientation. The clb2::LEU2 disruption was obtained
these separate functions in budding yeast. There are from B. Futcher and the TRP1/cen-CDC28–HA plasmid was ob-
two very different explanations for this situation. Bud- tained from C. Wittenberg.
ding yeast may have fundamentally different forms of
CAK than other species; perhaps an ancestral gene for
BuffersCAK duplicated and evolved separate functions in the
Protease inhibitors: the 13 protease inhibitor mix contained 10 mg/
yeast lineage. Alternatively, other eukaryotes may also ml each of leupeptin, chymostatin, and pepstatin (Chemicon). EB:
contain a Cak1p-like CAK, and the finding that p40MO15 80 mM b-glycerophosphate [pH 7.3], 20 mM EGTA, 15 mM MgCl2,
and Crk1/Mop1 have CAK activity may be an in vitro 10 mM DTT, 1 mg/ml ovalbumin, and 103 protease inhibitors. Other
buffers are described where they are used.phenomenon. We find the latter possibility intriguing.
Cell
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Yeast Extracts mM NaCl, 0.1 mM EDTA, 1 mM MgCl2, 1 mM DTT, and 0.23 protease
inhibitors) and loaded onto a 70 ml diethylaminoethyl (DEAE)–For small-scale yeast extracts, cells were grown at the indicated
temperatures and harvested in log-phase (A600 5 0.1–0.6) by centrifu- Sepharose FF column (2.5 cm 3 15 cm; Pharmacia) at 0.3 ml/min.
Proteins were eluted with a 0%–20% gradient (700 ml total) of buffergation for 4 min at 5000 3 g. The cell pellet (0.2–0.3 g) was resus-
pended in 1 ml of lysis buffer (20 mM Tris–HCl [pH 7.9], 100 mM B (buffer A containing 1 M NaCl) in 12 ml fractions. Fractions 71–82
(z150 mM NaCl) were pooled, and ammonium sulfate was addedNaCl, 10 mM MgCl2, 1 mM EDTA, 5% glycerol, 2 mM DTT, and 13
protease inhibitors). We added 0.8 g of glass beads (acid washed, to 40%. After 20 min at 08C, the precipitated proteins were pelleted
by centrifugation for 30 min at 15,500 rpm in a Sorvall SA-600 rotor,0.5 mm diameter; Sigma) and disrupted cells by bead beating (Klek-
amp and Weil, 1982) using a Mini-Beadbeater-8 (Biospec Products) and the pellet was resuspended in2.5 ml of buffer C (50mM NaH2PO4
[pH 6.8], 0.1 mM EDTA, 1 mM MgCl2, 10% glycerol, 0.1% Tweenfor 1 min at the maximum setting, followed by cooling in an ice–
water–NaCl bath (approximate temperature 2108C) for 2 min. This 20, 1 mM DTT, 0.23 protease inhibitors). The extract was loaded
at 0.2 ml/min onto a freshly activated 5 ml phosphocellulose columnprocedure was repeated five times. Glass beads and cell debris
were removed by centrifugation at 48C for 10 min at 15,000 3 g in (1 cm 3 6.5 cm; P11, Whatman), and the flowthrough (fractions
5–10, 1 ml each) was collected and concentrated using Centricon-a microfuge. The supernatant was clarified by ultracentrifugation at
10 cells (Amicon). The buffer was changed to buffer D (20 mM PIPES48C for 30 min at 70,000 rpm using a TLA 100.2 rotor in a Beckman
[pH 6.8], 1 mM MgCl2, 10% glycerol, 0.1% Tween 20, 1 mM DTT,Optima Ultracentrifuge. The crude extract was aliquoted, frozen in
and 0.23 protease inhibitors) using Centricon-10 cells. The sampleliquid nitrogen, and stored at 2808C. Typical extract concentrations
was loaded onto a hydroxyapatite column (7.5 mm 3 75 mm; HA-ranged from 4–6 mg/ml.
1000, TosoHaas) at 1 ml/min, and proteins were eluted with a 0%–32P labeling of Cdc28p in vivo was performed according to Cis-
15% gradient (20 ml total) of buffer E (1 M KH2PO4 [pH 6.8], 1 mMmowski et al. (1995) using 1 mCi per 2 ml culture. Cells were grown
MgCl2, 10% glycerol, 0.1% Tween 20, 1 mM DTT, and 0.23 proteasefor 24 hr in phosphate-free CM medium lacking tryptophan and
inhibitors). Fractions 20–30 (1 ml each, 20–100 mM phosphate) werecontaining 150 mM KH2PO4 and then shifted to 378C in phosphate-
pooled, concentrated, and exchanged into buffer C (pH 7.0) con-free YPD. After 2 hr, the cell density was adjusted to 0.4, and 2 ml
taining 150 mM NaCl. This sample was chromatographed on acultures were labeled for 3 hr with H332PO4 (ICN). Extracts were
Superdex 200 column (HR 10/30, Pharmacia). Fractions 16–19 (1 mlprepared as described above, and denatured proteins (diluted into
each, z4,000–32,000 Da) were pooled, concentrated, and washed10 ml per sample of lysis buffer) were immunoprecipitated using a
with buffer A (pH 8.0) containing 50 mM NaCl, 10% (v/v) glycerol,mixture of an antiserum to the C-terminus of Cdc28p (a gift of C.
and 0.1% Tween 20. The sample was loaded at 1 ml/min onto aWittenberg, obtained from M. Cismowski) and the 12CA5 antibody.
Mono Q column (HR 5/5, Pharmacia) and eluted with a 5%–25%
gradient (20 ml total) of buffer A (pH 8.0) containing 1 M NaCl, 10%CAK Assays
glycerol, and 0.1% Tween 20. Fractions 20–24 (1 ml each, z150 mMCAK assays were performed essentially as described previously
NaCl) were pooled and concentrated. The buffer was changed to(Cismowski et al., 1995). A sample (5 ml of extract or column fraction)
buffer C (pH 7.0) containing 150 mM NaCl, and the sample waswas incubated for 30 min at room temperature with 5 ml of CAK
chromatographed on a Superdex 75 column (HR 10/30, Pharmacia).assay mix containing z200 nM p33cdk2–HA (or GST–Cdc28p), z250
Fractions 21–25 (0.5 ml each, z15,000–46,000 Da) were pooled,nM GST–cyclin B (or MBP–Clb2p), 1 mM ATP, 5 mM MgCl2, 50 mg/ concentrated, and washed into buffer F (25 mM Bis–Tris [pH 6.4],ml creatine kinase, and 35 mM phosphocreatine, in EB. The reaction
50 mM NaCl, 1 mM MgCl2, 0.1 mM EDTA, 10% glycerol, 0.1% Tweenwas terminated by adding 40 ml of EB. p33cdk2–HA was subsequently
20, 1 mM DTT, and 0.23 protease inhibitors) before chromatofocus-immunoprecipitated using the 12CA5 antibody to lower the back-
ing on a Mono P column (HR 5/5, Pharmacia). Proteins were elutedground caused by other histone H1 kinases in the yeast lysate.
at 0.5 ml/min with a 0%–100% gradient (20 ml total) of buffer GHistone H1 kinase assays were performed as described previously
(10% Polybuffer 74 [pH 5.0; Pharmacia], 50 mM NaCl, 1 mM MgCl2,(Solomon et al., 1990) and analyzed by phosphorimaging (Molecular
0.1 mM EDTA, 10% glycerol, 0.1% Tween 20, 1 mM DTT, and 0.23
Imager GS-250, Bio-Rad) and autoradiography. Samples purified
protease inhibitors). Fractions (0.5 ml each) were immediately neu-
through the phosphocellulose column step and beyond could be
tralized with 20 ml of 1 M HEPES (pH 8.0). Fractions 52–57 were
assayed directly for H1 kinase activity, without immunoprecipitation
pooled for protein sequencing following trichloroacetic acid precipi-
of p33cdk2–HA. Comparison of the CAK activities in two or more tation and excision of the Coomassie blue–stained band from a
samples was accomplished by matching signal intensities from dilu- polyacrylamide gel.
tionseries. The CAK activity of the crude extract used for purification Fractions at every step of the purification were analyzed for CAK
was defined as 1 U per 100 ml. activity. Throughout this paper, “purified CAK” refers to material
For direct phosphorylations of p33cdk2–HA and GST–Cdc28p, ap- purified through the Mono P column.
proximately 3.1 fmol of purified CAK was incubated with z200 nM
p33cdk2–HA and z250 nM GST–cyclin B or with z200 nM GST– Protein Expression and Purification
Cdc28p and z250 nM MBP–Clb2p in the presence of 20 mCi of HA-tagged human p33cdk2 and sea urchin GST–cyclin B were ex-
[g-32P]ATP, 10 mM ATP, and 25 mM MgCl2 in EB (final volume 16 pressed in E. coli and purified as described previously (Solomon et
ml). The reactions were terminated after 30 min at room temperature al., 1990; Connell-Crowley et al., 1993). MBP–Clb2p (a gift of M.
by the additionof 5 ml of 53 SDS–polyacrylamide gel electrophoresis Olson and R. Deshaies, Caltech, Pasadena, CA) was expressed and
(SDS–PAGE) sample buffer. Samples were processed as described purified as described by the manufacturer (New England Biolabs).
for the CAK assay above. The yield was approximately 2.2 mg per liter of culture. A GST–
Cdc28p baculovirus (a gift of W. Harper, Baylor College of Medicine,
Purification of CAK from Budding Yeast Houston, TX) was used to infect SF21 insect cells (O’Reilly et al.,
We rehydrated 320 g of freeze-dried yeast cells (YCS2, Sigma) in 8 1994). After 2 days, cells (approximately 66 3 106) were harvested
l of YPD for 2 hr at 308C. Cells were harvested by centrifugation for and extracted as described previously (Desai et al., 1992). GST–
5 min at 3000 rpm in a Sorvall GS-3 rotor. Approximately 1 kg of Cdc28p was purified as described for GST–cyclin B (Solomon et
yeast cells (wet weight) was ground under liquid nitrogen (Sorger al., 1990).
and Pelham, 1987) and resuspended in 2.0 l of lysis buffer (20 mM To construct GST–Cak1p, the CAK1 gene was first amplified by
Tris–HCl [pH 7.5], 100 mM KCl, 0.1 mM EDTA, 10% glycerol, 1 mM PCR using the following primers: 59-GGGGGATCC ATGAACTGGAT
DTT, 1 mM PMSF, 13 protease inhibitors). This extract was clarified AGTATAGAC and 39- GCGGAATTCTTATCAGGCGCCCAAGCTAGC
by filtration (glass wool and 150 mm nylon mesh), by low speed GTAGTCAGGAACGTCATATGGATAGGCGCC, which introduce a
centrifugation (15 min at 5,500 rpm in a Sorvall GS-3 rotor), and by BamHI site immediately upstream of the initiation ATG and append
ultracentrifugation for 30 min at 35,000 rpm in a Beckman Ti45 rotor. an HA peptide (GAYPYDVPDYASLGA) to the C-terminus of Cak1p.
The clarified lysate was fractionated by acetone precipitation at The BamHI–EcoRI fragment containing CAK1–HA was completely
258C. Proteins in the 15%–35% cut were collected by centrifugation sequenced and cloned into the BamHI–EcoRI sites of pGEX-2T
for 7 min at 5500 rpm in a Sorvall GS-3 rotor. The pellet was resus- (Smith and Johnson, 1988). GST–Cak1p was expressed by inoculat-
ing 8 l of LB/Amp with 450 ml of a saturated culture. The cells werepended in 105 ml of buffer A (20 mM triethanolamine [pH 8.0], 10
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grown for 3 hr at 378C followed by 1.5 hr at 168C. IPTG was added Cell cycle control by a complex of the cyclin HCS26 (PCL1) and the
kinase PHO85. Science 266, 1388–1391.to 0.4 mM, and growth was continued for 29.5 hr at 168C. Cells were
harvested and GST–Cak1p was purified as described for GST–cyclin Feaver, W.J., Svejstrup, J.Q., Henry, N.L., and Kornberg, R.D. (1994).
B (Solomon et al., 1990). Relationship of CDK-activating kinase and RNA polymerase II CTD
kinase TFIIH/TFIIK. Cell 79, 1103–1109.
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